---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-016235"
form_type: "8-K"
ticker: "MXCT"
cik: "0001287098"
company_name: "MAXCYTE, INC."
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T04:36:05.385974+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MaxCyte preliminary Q3 revenue $7.8-8.0M; cuts FY2023 revenue guidance to $34-36M

## Summary
- Q3 total revenue expected $7.8-8.0M, down 25-27% YoY; core revenue $6.4-6.6M, down 33-35% YoY.
- FY2023 total revenue guidance reduced to ~$34-36M; core revenue guidance lowered to $28-30M.
- SPL program-related revenue Q3 $1.4M vs $0.8M YoY; full-year SPL guidance unchanged at ~$6M.
- Company cites depressed cell and gene therapy funding, customer inventory, and elongation of preclinical activity.
- Ending cash expected ~$200M, unchanged from initial 2023 outlook.

## SEC filing metadata
- accession: 0001558370-23-016235
- form_type: 8-K
- ticker: MXCT
- cik: 0001287098
- company_name: MAXCYTE, INC.
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1287098/000155837023016235/0001558370-23-016235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1287098/000155837023016235/mxct-20231004x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-016235
- JSON: https://secwatch.observer/filing/0001558370-23-016235.json
- Plain text: https://secwatch.observer/filing/0001558370-23-016235.txt

## Key facts
- Earnings Releases
  MAXCYTE, INC. reported the quarter ended September 30, 2023 results: revenue $7.8 – 8.0 million. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2023
  - Revenue: $7.8 – 8.0 million
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: preliminary revenue for the third quarter ended September 30, 2023 and updated its full year 2023 revenue guidance. ​ Preliminary Third Quarter 2023 Revenue · Total revenue of $7.8 – 8.0 million in the third quarter of 2023, a decrease of 25 -27% compared to the third quarter of 2022; the decline is due to continued reduced customer activity in the sector. ·
  evidence_url: https://www.sec.gov/Archives/edgar/data/1287098/000155837023016235/0001558370-23-016235-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.